Mochida Pharmaceutical Co.,Ltd.

4534・Prime Market・Pharmaceuticals

Official website

Mochida Pharmaceutical Co.,Ltd.

4534・Prime Market・Pharmaceuticals

Official website

Mochida Pharmaceutical Co.,Ltd.4534

Reference Indicators

Market Cap

1,144¥100M

P/E (Forecast)

11.1x

P/B

0.8x

Dividend Yield (Forecast)

2.70%

ROE

5.8%

EV/EBITDA

7.3x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	110,179	103,261	102,885	105,159	116,951
Cost of Sales	50,626	48,146	50,815	51,371	60,690
Gross Profit	59,553	55,114	52,070	53,787	56,260
SG&A Expenses	45,161	46,607	46,267	45,661	46,113
Operating Income	14,392	8,507	5,802	8,126	10,147
Non-operating Income	455	665	510	591	1,514
Non-operating Expenses	48	87	275	649	466
Ordinary Income	14,799	9,085	6,037	8,067	11,195
Extraordinary Income	564	13	503	2	51
Extraordinary Losses	771	54	380	17	76
Pre-tax Income	14,591	9,044	6,160	8,052	11,171
Income Taxes	4,022	2,395	1,613	2,367	3,267
Net Income	10,569	6,649	4,547	5,685	7,903
EBITDA	17,081	11,179	8,610	11,066	13,126
Gross Margin	54.1%	53.4%	50.6%	51.1%	48.1%
Operating Margin	13.1%	8.2%	5.6%	7.7%	8.7%
ROA	6.5%	4.2%	2.9%	3.6%	4.3%
ROE	8.3%	5.2%	3.6%	4.4%	5.8%